文献速递糖尿病

丘脑神经元与生物能量功能在痛性糖尿病周围神经病变中的双磁共振波谱研究

Thalamic neuronal and bioenergetic function in painful diabetic peripheral neuropathy: a dual magnetic resonance spectroscopy study.
PubMed 文献 · Diabetologia · 2026-09-10

这项横断面研究纳入38例2型糖尿病患者(11例无痛性DPN、9例无DPN、18例痛性DPN)和11名健康志愿者,采用结构MRI及1H-MRS与31P-MRS评估丘脑体积、神经元功能与生物能量状态。丘脑体积组间无差异,但痛性DPN组NAA:Cho显著高于无痛性DPN组,Pi:ATP显著低于无痛性DPN组;痛性DPN组内疼痛强度与丘脑Pi:ATP相关,全队列NAA:Cho与Pi:ATP显著相关。提示无痛性DPN存在丘脑神经元与生物能量状态受损,而痛性DPN可能保留丘脑生物能量与神经元特征。

要点

  • 痛性DPN患者丘脑NAA:Cho高于无痛性DPN,Pi:ATP低于无痛性DPN。
  • 痛性DPN组内疼痛强度与丘脑Pi:ATP相关。
  • 31P-MRS代谢物有望作为痛性DPN的客观生物标志物。

核心结论

  • 无痛性DPN存在丘脑神经元功能受损和生物能量状态改变,可能符合氧化磷酸化受损。
  • 痛性DPN可能以丘脑生物能量与神经元特征的保留为核心中枢机制。
  • 31P-MRS所测代谢物未来或可作为痛性DPN或神经病理性疼痛的客观生物标志物。

研究设计与样本

  • 所有受试者在同一次研究访视中完成详细神经表型评估、脑结构MRI以及1H-MRS与31P-MRS双磁共振波谱检查。

主要发现

  • 丘脑体积在各组间无差异。
  • 以NAA:Cho评估的神经元功能存在显著组间差异,痛性DPN组NAA:Cho显著高于无痛性DPN组。
  • 以Pi:ATP评估的生物能量状态存在显著组间差异,痛性DPN组Pi:ATP显著低于无痛性DPN组。
  • 痛性DPN组内疼痛强度与丘脑Pi:ATP相关。
  • 全队列中NAA:Cho与Pi:ATP显著相关。

临床怎么用

  • 对痛性DPN患者可关注丘脑神经元与生物能量状态的中枢机制评估。
  • 31P-MRS代谢物有望在未来临床试验中作为痛性DPN或神经病理性疼痛的客观生物标志物。

局限性

  • 研究为横断面设计,无法推断因果。
  • 样本量较小,各组例数有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of this cross-sectional study was to investigate three imaging parameters in people with type 2 diabetes to examine the volume, neuronal function and bioenergetic status of the thalamus in painful diabetic peripheral neuropathy (DPN) compared with painless DPN. METHODS: Forty-nine participants were recruited: 38 with type 2 diabetes (of whom 11 had painless DPN, nine had diabetes without DPN and 18 had painful DPN) and 11 healthy volunteers. All underwent detailed neurological phenotyping, structural brain MRI, and dual 1H-MRS and 31P-MRS during the same study visit. RESULTS: Thalamic volume did not differ between groups. However, significant group differences were observed in neuronal function, as assessed by the N-acetylaspartate:choline (NAA:Cho) ratio, and in bioenergetics, as assessed by the inorganic phosphate:ATP (Pi:ATP) ratio. NAA:Cho was significantly higher in individuals with painful DPN than in those with painless DPN. The Pi:ATP ratio was significantly lower in individuals with painful DPN than in those with painless DPN. Moreover, within the painful DPN group, pain intensity correlated with thalamic Pi:ATP, and NAA:Cho significantly correlated with Pi:ATP across the whole cohort. CONCLUSIONS/INTERPRETATION: These findings suggest that an impaired thalamic neuronal and altered bioenergetic state, potentially consistent with impaired oxidative phosphorylation, exists in painless DPN, and that preservation of thalamic bioenergetic and neuronal profiles could be an important central mechanism of painful DPN. These findings may have clinical relevance as metabolites measured by 31P-MRS may have the potential to act as objective biomarkers of painful DPN or neuropathic pain in future clinical trials.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Sloan G, Anton A, Teh K, et al. Thalamic neuronal and bioenergetic function in painful diabetic peripheral neuropathy: a dual magnetic resonance spectroscopy study. Diabetologia. 2026. PMID: 42720751. doi:10.1007/s00125-026-06846-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。